Literature DB >> 18392123

HbA1c standardisation: history, science and politics.

W Garry John1, Andrea Mosca, Cas Weykamp, Ian Goodall.   

Abstract

Significant analytical improvements have occurred since glycated haemoglobin (GHb), measured as total HbA(1), was first used in routine clinical laboratories around 1977. Following the publication of the Diabetes Control and Complications Trial (DCCT) study in 1993 the issue of international standardisation became an important objective for scientists and clinicians. The lack of international standardisation led several countries to develop national standardisation programs. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Standardisation of HbA(1c) established a true international reference measurement system for HbA(1c) and the successful preparation of pure HbA(1c) calibration material that should lead to further improvements in inter-method and inter-laboratory variability. Reporting of HbA(1c) has been agreed using the units of mmol/mol (IFCC) and percent (National Glycohemoglobin Standardization Program, NGSP).

Entities:  

Year:  2007        PMID: 18392123      PMCID: PMC2282401     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  16 in total

1.  Global harmonization of hemoglobin A1c.

Authors:  David B Sacks
Journal:  Clin Chem       Date:  2005-04       Impact factor: 8.327

Review 2.  Standardization in laboratory medicine: new challenges.

Authors:  M Panteghini; J C Forest
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

3.  Recommendation for term and measurement unit for "HbA1c".

Authors:  Gunnar Nordin; René Dybkaer
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

4.  Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward.

Authors:  Mauro Panteghini; W Garry John
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

5.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

6.  A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards.

Authors:  C M Peterson; L Jovanovic; P Raskin; D E Goldstein
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

7.  Improved method for analysis of glycated haemoglobin by ion exchange chromatography.

Authors:  S Eckerbom; Y Bergqvist; J O Jeppsson
Journal:  Ann Clin Biochem       Date:  1994-07       Impact factor: 2.057

8.  Laboratory evaluation of the DCA 2000 clinic HbA1c immunoassay analyser.

Authors:  W G John; R Edwards; C P Price
Journal:  Ann Clin Biochem       Date:  1994-07       Impact factor: 2.057

9.  A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom.

Authors:  B J Boucher; J M Burrin; B J Gould; P N John; G Lewis; C Owens; R Paisey; C A Pennock; P Y Poon; I S Ross; S G Welch; J M White
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

10.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

View more
  12 in total

Review 1.  Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-07-01

2.  Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine-year period.

Authors:  Pierre-Alain Morandi; André Deom; Dagmar Kesseler; Richard Cohen
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.

Authors:  Ben Schöttker; Elke Raum; Dietrich Rothenbacher; Heiko Müller; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2011-09-27       Impact factor: 8.082

Review 4.  A review of the challenge in measuring hemoglobin A1c.

Authors:  Cas Weykamp; W Garry John; Andrea Mosca
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.

Authors:  B Schöttker; H Müller; D Rothenbacher; H Brenner
Journal:  Diabetologia       Date:  2012-09-19       Impact factor: 10.122

Review 6.  What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes?

Authors:  Rolf Hinzmann; Christof Schlaeger; Cam Tuan Tran
Journal:  Int J Med Sci       Date:  2012-09-29       Impact factor: 3.738

7.  Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study.

Authors:  Tamio Teramoto; Kohji Shirai; Hiroyuki Daida; Nobuhiro Yamada
Journal:  Cardiovasc Diabetol       Date:  2012-03-23       Impact factor: 9.951

8.  Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.

Authors:  Margaret A Stone; Guillaume Charpentier; Kris Doggen; Oliver Kuss; Ulf Lindblad; Christiane Kellner; John Nolan; Agnieszka Pazderska; Guy Rutten; Marina Trento; Kamlesh Khunti
Journal:  Diabetes Care       Date:  2013-04-29       Impact factor: 19.112

Review 9.  Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes.

Authors:  Kamlesh Khunti; Hamidreza Mani; Felix Achana; Nicola Cooper; Laura J Gray; Melanie J Davies
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 10.  Exhaled breath analysis: a review of 'breath-taking' methods for off-line analysis.

Authors:  Oluwasola Lawal; Waqar M Ahmed; Tamara M E Nijsen; Royston Goodacre; Stephen J Fowler
Journal:  Metabolomics       Date:  2017-08-19       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.